What caused the HCCCW stock bounce on 02 Feb 2026?

The jump to **$0.49** was driven by a volume spike (**1,023,467** shares) and short-term buying in an oversold setup. There was no confirmed fundamental news; moves likely reflect trading flows and speculation around a possible business combination.

What is Meyka AI’s view on HCCCW stock valuation?

Meyka AI gives HCCCW a score of **62.65/100 (B, HOLD)**. Key valuation flags include PE **-33.76**, book value per share **-0.01**, and near-zero cash per share, indicating limited intrinsic value until a transaction occurs.

What are short-term price targets for HCCCW stock?

Short-term resistance sits at **$0.58** with an intraday target near **$0.60** for momentum trades. A failed bounce could push price toward **$0.20** or lower to **$0.10** in a liquidity-driven selloff.

How should traders manage risk on HCCCW stock?

Use tight stops around **$0.45**, limit position size given volatility, and avoid holding through news gaps without confirmed merger updates. This is a tactical trade, not a long-term investment thesis.

US Stocks

HCCCW (Healthcare Capital Corp., NASDAQ) up 16.67% to $0.49 on 02 Feb 2026: Oversold bounce eyes $0.58 resistance

ByDanny Kontos February 3, 2026

HCCCW stock jumped 16.67% to $0.49 at market close on 02 Feb 2026 in the United States (NASDAQ). The move followed a low of $0.45 and a high of $0.58 on volume of 1,023,467 shares, a sign of renewed short-term interest in this shell company. Market closed session traded with a gap higher from an open of $0.74 after a previous close of $0.42. As an oversold bounce setup, we see this as a tactical rebound rather than a fundamental turnaround. Meyka AI’s market tools flag the stock for a short trade or hold-and-watch approach while consensus remains sparse